Results 1 to 10 of about 832 (157)

Clinical factors associated with severe hypophosphataemia after kidney transplant [PDF]

open access: yesBMC Nephrology, 2021
Background The mechanism by which hypophosphataemia develops following kidney transplantation remains debated, and limited research is available regarding risk factors. This study aimed to assess the association between recipient and donor variables, and
Maximilian R. Ralston   +3 more
doaj   +2 more sources

Severe Symptomatic Hypophosphataemia as a Complication of Parenteral Iron Replacement [PDF]

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2020
Parental iron replacement is given to patients with severe iron deficiency or intolerance to oral iron. Hypophosphataemia has been reported to occur as a complication of parental iron replacement, and is postulated to be related to the carbohydrate ...
Kevin Kim-Jun Teh   +4 more
doaj   +2 more sources

Hypophosphataemia risk associated with ferric carboxymaltose in heart failure: A pooled analysis of clinical trials [PDF]

open access: yesESC Heart Failure, 2023
Aims Iron deficiency is a common finding among patients with heart failure (HF) and is associated with adverse outcomes, including decreased quality of life, increased risk of hospitalization, and decreased survival.
Giuseppe MC Rosano   +2 more
doaj   +2 more sources

X-Linked Hypophosphataemia

open access: yesLancet, The
X-linked hypophosphataemia is a rare genetic disorder that causes renal phosphate wasting, impaired mineralisation of teeth and bones, skeletal deformities and limited mobility, all of which significantly impact on health and quality of life. This clinical review examines the recommendations for diagnosing, treating and monitoring adults with the ...
Craig F. Munns   +2 more
exaly   +10 more sources

Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review

open access: yesDrugs in Context, 2021
Third-generation intravenous (i.v.) iron preparations are safe and efficacious and are increasingly used in the treatment of iron-deficiency anaemia.
Xenophon Kassianides, Sunil Bhandari
doaj   +1 more source

A man with hypophosphataemia [PDF]

open access: yesBMJ, 2011
A 76 year old man was referred with hypophosphataemia. He had a history of hypertension and gout. He presented with a six month history of generalised bone pain and lower limb weakness. Examination showed weak hip flexion and extension (power 4/5). Complete blood count, serum glucose, and kidney function tests were normal. Serum calcium was 2.33 mmol/L
Lam, CW   +5 more
openaire   +4 more sources

Hyperventilation and hypophosphataemia [PDF]

open access: yesAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2009
We describe a case where extensive investigations were utilized to identify the aetiology of hypophosphataemia in a patient presenting with non-specific symptoms. The diagnosis of hyperventilation-induced hypophosphataemia was eventually established. Hyperventilation is a relatively common cause of isolated hypophosphataemia, but is easily overlooked ...
B N, Datta, M D, Stone
openaire   +2 more sources

Clinical, haematological and some biochemical variations hypophosphataemia in buffaloes before and after treatment at Assiut Government [PDF]

open access: yesJournal of Veterinary Medical Research, 2007
A total number of 28 buffaloes aged between 5-7years, body weight ranged between 400-500 kg, and belonged to private farms at Assiut Governorate constituted the materials of this study. Twenty of them showed the classical signs of hypophosphataemia while
M. E Radwan, H. Z. Rateb
doaj   +3 more sources

X-linked hypophosphataemic rickets in children: clinical phenotype, therapeutic strategies, and molecular background

open access: yesEndokrynologia Polska, 2021
INTRODUCTION: X-linked hypophosphataemic rickets (XLHR) is the most common form of hypophosphataemic rickets (HR), which is caused by mutations in the PHEX gene.
Monika Obara-Moszynska   +5 more
doaj   +1 more source

Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status

open access: yesBMC Gastroenterology, 2020
Background Intravenous iron replacement is recommended for iron-deficient patients with inflammatory bowel disease (IBD), but may be associated with hypophosphataemia, predisposing to osteomalacia and fractures. This study aimed to evaluate the incidence
Wendy Fang   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy